US church leads fight against 'tranq' drug crisis amid fentanyl surge

A US church is on the frontline of efforts to combat the spread of 'tranq' (xylazine), a synthetic drug often mixed with fentanyl, which is reshaping the drug landscape. The report highlights the growing public health challenge posed by tranq, though specific data on its prevalence and impact remains unclear. This underscores the evolving nature of the opioid crisis and the need for targeted public health responses.